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Background: Compared with European Americans, African Americans (AAs) exhibit
lower levels of the cardio-metabolically protective adiponectin even after accounting for
adiposity measures. Because few studies have examined in AA the association between
adiponectin and genetic admixture, a dense panel of ancestry informative markers (AIMs)
was used to estimate the individual proportions of European ancestry (PEA) for the AAs
enrolled in a large community-based cohort, the Jackson Heart Study (JHS). We tested
the hypothesis that plasma adiponectin and PEA are directly associated and assessed the
interaction with a series of cardio-metabolic risk factors.
Methods: Plasma specimens from 1439 JHS participants were analyzed by ELISA for
adiponectin levels. Using pseudo-ancestral population genotype data from the HapMap
Consortium, PEA was estimated with a panel of up to 1447 genome-wide preselected
AIMs by a maximum likelihood approach. Interaction assessment, stepwise linear and
cubic multivariable-adjusted regression models were used to analyze the cross-sectional
association between adiponectin and PEA.
Results: Among the study participants (62% women; mean age 48 ± 12 years), the
median (interquartile range) of PEA was 15.8 (9.3)%. Body mass index (BMI) (p = 0.04)
and insulin resistance (p = 0.0001) modified the association between adiponectin and
PEA. Adiponectin was directly and linearly associated with PEA (β = 0.62 ± 0.28, p = 0.03)
among non-obese (n = 673) and insulin sensitive participants (n = 1141; β = 0.74 ± 0.23,
p = 0.001), but not among those obese or with insulin resistance. No threshold point
effect was detected for non-obese participants.
Conclusions: In a large AA population, the individual proportion of European ancestry
was linearly and directly associated with plasma adiponectin among non-obese and non
insulin-resistant participants, pointing to the interaction of genetic and metabolic factors
influencing adiponectin levels.
Keywords: cohort study, adiponectin, individual European ancestry, minorities, African Americans, obesity, insulin
resistance
INTRODUCTION
Complex and common chronic diseases such as cardiovascular
disease (CVD) which affect African Americans (AAs) dispropor-
tionally are likely caused by many genetic and environmental
factors and their interactions (Go et al., 2014). Assessing asso-
ciations between self-reported race/ethnicity with these diseases
is often complicated due to heterogeneity within racial/ethnic
groups (Burchard et al., 2003). The most abundant product of
adipocytes, adiponectin is a global endophenotype for obesity
and cardio-metabolic disease risk (Choi et al., 2004; Vettor et al.,
2005; Wannamethee et al., 2007; Bidulescu et al., 2013a), and a
potential mediator of the cardio-metabolic consequences of obe-
sity (Ouchi et al., 2006).When compared to European Americans,
AAs exhibit lower levels of the cardio-metabolically protective
adipokine named adiponectin even after accounting for adiposity
measures (Patel et al., 2006; Bidulescu et al., 2013b). The reason
for this ethnic difference is still unclear.
African Americans in the United States are variably admixed
with African and European ancestry (Parra et al., 2001). Due
to this heterogeneity, genetic admixture analysis offers a unique
opportunity for studying the role of genetic factors within a
single, admixed population, controlling for socioeconomic and
behavioral factors as well as comorbidities (Pritchard et al., 2000).
Nevertheless, few studies have examined in AAs the association
between adiponectin and individual ancestry estimates, as esti-
mated with ancestry informative markers (AIMs), genetic loci
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showing alleles with large frequency differences between popu-
lations (Wassel Fyr et al., 2007). In addition, these studies used
relatively few AIMs and small AA sample sizes.
We thus employed a relatively dense panel of AIMs to esti-
mate the individual proportions of European ancestry (PEA)
for the AAs enrolled in a large community-based cohort, the
Jackson Heart Study (JHS) (Smith et al., 2004; Xu and Jin,
2008), in order to assess the association of this proportion with
serum levels of the adiponectin. The hypothesis tested was that
serum adiponectin and PEA are directly associated. For inter-
action assessment purposes, we also queried if obesity, insulin




JHS is a single-site, prospective cohort study of the risk factors
and causes of heart disease in adult AAs. A probability sample
of 5301 AAs, aged 21–94 years, residing in a three county area
surrounding the city of Jackson, MS, were recruited and exam-
ined at baseline (2000–2004) by certified technicians according to
standardized protocols. Clinic visits and interviews occur approx-
imately every 4 years. Annual follow-up interviews and cohort
surveillance are ongoing. An overview of the JHS (Taylor, 2005)
and details of the study design (Carpenter et al., 2004), recruit-
ment protocol (Wyatt et al., 2003) and data collection methods
(Carpenter et al., 2004) are published elsewhere.
The sample for this study included 1439 JHS participants (62%
women; mean age 48± 12 years) with available DNA through the
Candidate-Gene Association Resource (CARe) Study (Musunuru
et al., 2010) and that had serum adiponectin measured (Bidulescu
et al., 2011). Written consent was obtained from each participant
at the inception of the study, and the study was approved by the
participating JHS institutions: Jackson State University, Tougaloo
College and the University of Mississippi Medical Center. The
study protocol for the ascertainment of the adiponectin samples
was approved by the Morehouse School of Medicine Institutional
Review Board.
ADIPONECTIN MEASUREMENTS
Venous blood samples were withdrawn from each subject at base-
line examination after more than 8 h of fasting as described
elsewhere (Carpenter et al., 2004). Vials of serum were stored
at the JHS central repository in Minneapolis, MN, at −80◦C
until assayed. Adiponectin concentration was measured as total
adiponectin by an ELISA system (R&D Systems; Minneapolis,
MN) (Bidulescu et al., 2011). The inter-assay coefficient of vari-
ation was 8.8%. No biological degradation has been described
using stored specimens, indicating a high validity for our
measurements.
PROPORTION OF EUROPEAN ANCESTRY
In order to estimate ancestry we used a set of particularly infor-
mative DNA polymorphisms that have been termed AIMs due
to their information content for distinguishing particular ances-
tral groups that correspond to continental populations. The
proportion of European ancestry (as an estimate of the global
proportion of individual European ancestry) was estimated for
each individual using a panel of 1447 AIMs distributed across the
genome. AIMs were selected using pseudo-ancestral population
genotype data from the International HapMap Consortium to
be informative for African vs. European ancestry (Smith et al.,
2004; Xu and Jin, 2008). Ancestry proportions were estimated
using a maximum likelihood approach in which the sum of the
log-likelihood of individual ancestry from all the markers was
maximized as a function of that person’s ancestry, with a range
between 0 and 1 (Chakraborty andWeiss, 1986; Long, 1991; Parra
et al., 1998). If one considers an admixed population, K3, as the
result from the genetic admixture of subjects from two ances-
tral populations, K1 and K2, then s1 and (1-s1) will represent
the ancestry proportion from population K1 and K2, separately.
If one represents Gi as the genotype for an admixed individ-
ual at the ith locus, then for n loci, likelihood can be defined
as: L(s1) =∏ i = 1 to n Pr(Gi), where Pr is the actual proportion.
Instead of maximizing likelihood, it is computationally simple
to maximize its natural logarithm: loge [L(s1)] =∑ i = 1 to n
loge[Pr(Gi)].
The MLE approach has been implemented in the program
IAE3CI, which was kindly provided by Dr. Mark D. Shriver.
The program requires the information of allele frequencies from
each ancestral population and admixed subjects’ genotyping data
(Chakraborty et al., 1986; Hanis et al., 1986; Bonilla et al.,
2004) We also compared our method with the algorithm for
global ancestry estimation implemented in the other used pro-
grams. Tsai et al. (2005) evaluated the performances of three
different methods for estimating global genetic ancestry: MLE,
ADMIXMAP and STRUCTURE, through various simulated data
sets and real data from Latino subjects participating in a genetic
study of asthma. All three methods provided similar information
on the accuracy of ancestral estimates. The Pearson’s correlation
coefficients, r, for ancestry estimates were >0.99 between MLE,
ADMIXMAP, and STRUCTURE.
CVD RISK FACTORS USED AS COVARIATES
CVD risk factor information was ascertained during the JHS
Exam 1 (2000–2004) through standard procedures and ques-
tionnaires. In all participants, the clinic visit included physical
examinations, anthropometry, survey of medical history and
current medication use and collection of blood and urine spec-
imens for biological assessment. In-clinic standing height and
weight were measured in lightweight examination clothing with-
out shoes or constricting garments. We calculated body mass
index (BMI) as weight in kilograms divided by height in meters
squared (kg/m2). The average of two sitting blood pressure, mea-
sured at 1-min intervals after a 5-min silent rest, was used for
analysis. Participants were considered current smokers if they
smoked at the time of the baseline examination. Current alco-
hol use was defined as “yes” if they drank in the past 12 months.
Lipid variables, fasting plasma glucose and fasting insulin were
measured using standard laboratory techniques. Insulin resis-
tance was calculated using the homeostasis model assessment for
insulin resistance (HOMA-IR) (Matthews et al., 1985), and used
as a continuous variable as well as a categorical variable. As a
categorical variable, insulin resistance was defined as the upper
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quartile of the distribution as indicated by the fact that, consid-
ering the cardio-metabolic risk to establish the cut-off points for
HOMA-IR, values between the 70th and the 75th percentile of
HOMA-IR levels appears appropriate (Gayoso-Diz et al., 2013).
Diabetes was defined as a fasting plasma glucose level of at least
7.0mmol/l or if the subject was being treated with insulin or a
hypoglycemic agent. Physical activity was assessed with a phys-
ical activity survey instrument administered by interview. The
questionnaire assessed four different domains of physical activ-
ity (active living, work, home and garden, and sport and exercise
indexes). A total score was composed as the sum of these domains
(maximum of 24), with a higher score indicating a higher level
of total physical activity (Dubbert et al., 2005). Obesity was
defined by a BMI≥ 30 kg/m2. C-reactive protein (CRP) was mea-
sured in duplicate by the immunoturbidimetric CRP-Latex assay
from Kamiya Biomedical Company using a Hitachi 91l analyzer,
according to the manufacturer’s high-sensitivity protocol. The
inter-assay coefficients of variation on control samples repeated
in each assay were 4.5% at a CRP concentration of 0.45mg/L and
4.4% at 1.56mg/L.
STATISTICAL ANALYSIS
A cross-sectional analysis was performed. For each individual
CVD risk factor, the Student unpaired t-test or the chi-square
test was implemented in order to assess the significance of the
difference between participants by sex.
Serum adiponectin levels were log-transformed in order to
normalize their distribution and to meet assumptions about nor-
mality. Age- and sex-adjusted Pearson correlation coefficients
between adiponectin, proportion of European ancestry and the
main study covariates were calculated. Assessment of the inter-
action by sex, BMI, waist circumference, and insulin resistance
were conducted using a log-likelihood testing. The effect mea-
sure modification potential of obesity and insulin resistance was
assessed using interaction terms in the fully adjusted models.
Multivariable linear regression models with a stepwise forward
selection procedure were constructed with adiponectin as the
dependent variable and PEA as the main independent variable.
To confirm our findings, we have run a sensitivity analysis among
participants without diabetes. For all analyses, the statistical sig-
nificance was set at P ≤ 0.05 for main and interactive effect.
We also investigated the structure of the relationship between
log-transformed serum adiponectin levels with proportion
of European ancestry using cubic regression splines. In a
multivariable-adjusted generalized additive model, we compared
the deviance between models with and without proportion of
ancestry. A non-linear relation was determined by a significant
deviance and estimated degrees of freedom greater than 3.
All computations were performed using the SAS software
version 9.2 (SAS® Institute Inc., Cary, North Carolina).
RESULTS
Our study sample comprised 897 women and 542 men. The aver-
age age was 48 ± 12 years. The serum adiponectin levels were
statistically different between sexes: 5.3 ± 3.7μg/mL in women
and 3.8 ± 2.7μg/mL in men. Among our study participants, the
median (interquartile range) of PEA was 15.8 (9.3)%. There were
statistically significant differences between sexes for adiponectin,
BMI, waist circumference, triglycerides, HDL-cholesterol, fasting
plasma glucose, HOMA-IR, type 2 diabetes, and CRP (Table 1)
Among our study participants, 766 were obese, 209 were classified
as having type 2 diabetes and 298 as insulin resistant partici-
pants (by HOMA-IR); 249 participants do not have insulin level
measured, and thus did not have HOMA-IR estimated.
CORRELATIONS BETWEEN ADIPONECTIN PROPORTION OF EUROPEAN
ANCESTRY AND OTHER VARIABLES
Age- and sex-adjusted correlates of log-transformed adiponectin
with the proportion of European ancestry and the CVD risk fac-
tors considered in our study are presented in Table 2. Adiponectin
was significantly associated with the majority of covariates with
the exception of systolic blood pressure, physical activity, and pro-
portion of European ancestry (Table 2). Proportion of European
ancestry was significantly associated with adiponectin and waist
circumference, but not with HOMA-IR or BMI (Table 2). Thus,
bivariate analyses among all our study participants revealed a
statistically significant but weak correlation between PEA and
adiponectin.
MULTIVARIABLE-ADJUSTED LINEAR REGRESSION MODELS OF
ADIPONECTIN AND PROPORTION OF EUROPEAN ANCESTRY
Body mass index (p = 0.04) and insulin resistance (p = 0.0001)
were effect modifiers of the association PEA—adiponectin. On
Table 1 | Descriptive characteristics (mean ± standard deviation, or
percentage) of study participants (N = 1439) stratified by sex.
Women Men Whole
(N = 897) (N = 542) sample
Age (years) 47 ± 12 49 ± 11 48 ± 12
Adiponectin (μg/mL) 5.3 ± 3.7 3.8 ± 2.7* 4.7 ± 3.4
PEA 17.0 ± 8.9 17.8 ± 8.1 17.3 ± 8.1
BMI (kg/m2; n = 1437**) 33.0 ± 7.4 29.5 ± 5.7* 31.7 ± 7.0
WC (cm; n = 1438) 99.3 ± 16.5 99.0 ± 14.2* 99.2 ± 15.7
TG (mg/dL; n = 1343) 97.0 ± 70.0 113.5 ± 118.5* 103.3 ± 91.7
HDL-C (mg/dL; 1344) 53.6 ± 13.8 45.5 ± 11.5* 50.5 ± 13.6
FG (mg/dL; n = 1344) 95.3 ± 27.5 96.7 ± 30.1* 95.8 ± 28.5
HOMA-IR (n = 1190) 3.7 ± 2.5 3.2 ± 2.0* 3.5 ± 2.3
Type 2 diabetes (%; n = 212) 16.3 12.1* 14.7
SBP (mm Hg; n = 1437) 121.5 ± 17.4 123.0 ± 16.2 122.1 ± 17.0
DBP (mm Hg; n = 1437) 77.7 ± 10.0 81.1 ± 10.5 79.0 ± 10.3
PA 8.8 ± 2.4 9.2 ± 2.4 8.9 ± 2.4
Alc. Drink. (% yes) 50 66 56
CRP (mg/dL) 6.1 ± 7.9 3.0 ± 5.5* 4.9 ± 7.2
Education (% > High School) 38 36 37
PEA indicates proportion of European ancestry; BMI, body mass index; WC,
waist circumference; TG, triglycerides; HDL-C, high-density lipoprotein choles-
terol; FG, fasting plasma glucose; HOMA-IR, insulin resistance by homeostasis
assessment model HOMA-IR; SBP, systolic blood pressure; DBP, diastolic blood
pressure; PA, total physical activity score; Alc. Drink., Alcohol drinking in the past
year; CRP, C-reactive protein.
*Statistical significant difference (t-test) by sex.
**Characteristics/parameters with less than the maximum number of 1439
participants are indicated in brackets (as the n number).
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Table 2 | Age- and sex-adjusted Pearson correlation coefficients
between adiponectin, proportion of European ancestry and
covariates (N = 1439).
Adiponectin* Proportion of European ancestry
Coefficient p-value Coefficient p-value
Adiponectin* – – 0.06 0.03
PEA 0.06 0.03 – –
BMI (kg/m2) −0.19 <0.0001 −0.05 0.11
WC (cm) −0.25 <0.0001 −0.05 <0.0001
TG −0.21 <0.0001 0.05 0.11
HDL-C 0.29 <0.0001 −0.02 0.52
FG −0.22 <0.0001 −0.05 0.09
HOMA-IR −0.33 <0.0001 −0.03 0.38
SBP −0.03 0.31 −0.04 0.15
DBP −0.04 0.19 −0.03 0.36
PA −0.01 0.76 −0.06 0.04
CRP −0.14 <0.0001 −0.01 0.66
PEA indicates proportion of European ancestry; BMI, body mass index; WC,
waist circumference; p, p-values; TG, triglycerides; HDL, high density lipoprotein
cholesterol; FPG, fasting plasma glucose; HOMA-IR, insulin resistance (home-
ostasis model assessment); SBP, systolic blood pressure; DBP, diastolic blood
pressure; PA, total physical activity score; CRP, C-reactive protein.
*Logarithmically-transformed values.
the contrary, sex (p = 0.64) and waist circumference (p = 0.83)
were not found to be effect modifiers. Among non-obese indi-
viduals (n = 673), adiponectin was directly associated with PEA
(β = 0.62 ± 0.28, p = 0.03), after adjustment for sex, waist cir-
cumference, systolic blood pressure, HOMA-IR, HDL-cholesterol
and physical activity, as indicated by the stepwise procedure
(Table 3).
Among participants without insulin resistance (n = 1141),
adiponectin was also directly associated with PEA (β = 0.74 ±
0.23, p = 0.001), after adjustment for age, sex, BMI, waist
circumference , HDL-cholesterol and CRP, as indicated by
the stepwise procedure (Table 3). In our sensitivity analyses,
among participants without diabetes (n = 1106), there was a
similar direct association between adiponectin and PEA (β =
0.52 ± 0.22, p = 0.02).
LINEAR RELATIONSHIP BETWEEN ADIPONECTIN AND PROPORTION
OF EUROPEAN ANCESTRY
Figure 1 shows plots relating PEA to adiponectin after mul-
tivariable adjustment and stratification by obesity status
(Figures 1A,B) and by insulin resistance status (Figures 1C,D).
Test of deviation from linearity showed that log adiponectin
was linearly and significantly (p = 0.021) related to PEA in the
non-obese participants but not in the obese group (Figure 1B
vs. Figure 1A). It also showed that adiponectin was non-linearly
and borderline significantly (p = 0.091) related to PEA in a
group of insulin resistant participants (results not shown), but
after fitting a cubic regression smoother with greater than three
degrees of freedom, it was obvious that the relation was linear but
not significant (p = 0.418; Figure 1C). Adiponectin was on the
other hand linearly and highly significantly (p = 0.0094) related
Table 3 | Linear multivariable association between adiponectin and
proportion of European ancestry.
By obesity status Non-obese (N = 673)* Obese (N = 766)*
β-coefficient p-value β-coefficient p-value
PEA 0.62 0.03 – 0.81
Age – 0.61 0.005 0.04
Sex −0.28 <0.0001 −0.32 <0.0001
WC −0.01 0.01 – 0.31
TG – 0.77 – 0.99
HDL 0.01 <0.0001 0.01 <0.0001
HOMA-IR −0.09 <0.0001 −0.06 <0.0001
SBP 0.003 0.06 – 0.10
DBP – 0.38 – 0.73
PA −0.02 0.06 – 0.98
Alc. Drink. – 0.33 – 0.91
CRP – 0.29 −0.08 0.01
Education – 0.22 – 0.56
By insulin resist. status Without IR (N = 1141)** With IR (N = 298)***
β-coefficient p-value β-coefficient p-value
PEA 0.74 0.001 – 0.41
Age 0.005 0.005 0.006 0.06
Sex −0.25 <0.0001 −0.24 0.001
BMI 0.01 0.003 – 0.41
WC −0.01 <0.0001 – 0.28
TG – 0.30 – 0.90
HDL 0.01 <0.0001 0.01 0.02
SBP – 0.16 – 0.18
DBP – 0.19 – 0.93
PA – 0.10 – 0.61
Alc. Drink. – 0.41 – 0.70
CRP −0.08 0.01 – 0.37
Education – 0.83 0.006 0.06
PEA indicates proportion of European ancestry; BMI, body mass index; WC,
waist circumference; TG, triglycerides; HDL, high density lipoprotein cholesterol;
HOMA-IR, insulin resistance (homeostasis model assessment); SBP, systolic
blood pressure; DBP, diastolic blood pressure; PA, total physical activity score;
Alc. Drink., Alcohol drinking in the past year; CRP, C-reactive protein.
*R2 for the whole model = 0.22.
**R2 for the whole model = 0.10.
***R2 for the whole model = 0.20.
to PEA among non-insulin resistant participants (Figure 1D).
Overall the structure of relation between adiponectin to PEA
seems to be linear, especially among non-obese participants.
DISCUSSION
PRINCIPAL FINDINGS
In a large community-based AA sample, the individual propor-
tion of European ancestry was directly associated with serum
adiponectin among non-obese and among insulin sensitive par-
ticipants. There was not an association among obese participants
or among those with insulin resistance. Across the entire dis-
tribution of adiponectin, there was a linear and statistically sig-
nificant direct association between adiponectin and PEA among
non-obese participants.
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FIGURE 1 | Linear relationship between adiponectin and the
proportion of European ancestry in non-obese and non-insulin
resistant participants. Legend: Relationship between the proportion of
European ancestry and adiponectin levels (log-transformed), as described
using cubic regression splines, stratified by obesity and insulin resistance
levels; (A) Obese participants; (B) Non-Obese participants; (C) Participants
with insulin resistance (IR); (D) Participants without insulin resistance
(non-IR).
IN THE CONTEXT OF PREVIOUS LITERATURE
Few previous studies used estimates of individual ancestry to
assess its association with CVD or other phenotypes (Wassel et al.,
2009; Allison et al., 2010). A multivariable analysis in the Health
ABC study showed a strong association between higher European
ancestry and adiponectin levels (Wassel Fyr et al., 2007). The
mean (standard deviation) of European ancestry among the
1241 AAs enrolled in that study was 22.3 (15.9)%, thus slightly
higher compared to our investigation (Wassel Fyr et al., 2007).
Estimates of European ancestry in our cohort were more con-
sistent with other studies among AAs. For example, Parra and
colleagues observed around 20% European ancestry for AA indi-
viduals from Pittsburgh, PA and around 12% in Charleston, SC
(Parra et al., 1998).
African Americans in the United States are a heterogeneous
group, variably admixed with African and European ancestry
(Parra et al., 2001; Campbell et al., 2005). Because genetic-
association studies are often performed in population samples
of unrelated individuals to identify susceptibility loci for com-
plex human traits, if subjects are sampled from two or more
subpopulations for which the frequencies of marker alleles and
traits differ, spurious associations may arise due to confounding
by population substructure (Pritchard et al., 2000; Risch et al.,
2002; Tang et al., 2005). Due to this heterogeneity, genetic admix-
ture analysis offers a unique opportunity for studying the role of
genetic factors within a single, admixed population, independent
of social factors, and comorbidities. Ancestry informative mark-
ers, AIMs, are genetic loci showing alleles with large frequency
differences between populations that can be used to estimate
bio-geographical ancestry at the level of the population and indi-
vidual. Ancestry estimates at both the subgroup and individual
level can be directly instructive regarding the genetics of the
phenotypes that differ qualitatively or in frequency between pop-
ulations (Shriver et al., 2003). Specifically, an association between
genetic ancestry and a disease phenotype within an admixed
group such as AAs may be an indicator of genetic factors under-
lying differential expression among racial groups (Peralta et al.,
2010).
Adiponectin, an adipose-specific protein, is generally nega-
tively associated with adiposity, insulin sensitivity, and diabetes
(Cnop et al., 2003; Duncan et al., 2004; Cote et al., 2005; Li et al.,
2009). Nevertheless, it has been shown that ethnicity modifies the
relationships of adiponectin and insulin resistance with obesity.
For example, a recent study showed that BMI, insulin, and insulin
resistance assessed through the homeostasis model assessment
(HOMA) correlated significantly with adiponectin levels only in
Caucasian women (Hulver et al., 2004). In another study, nor-
mal weight African women showed marginally lower adiponectin
levels than their Caucasian counterparts (Schutte et al., 2007).
Moreover, no differences in adiponectin were shown for over-
weight and obese African and Caucasian women (Schutte et al.,
2007). These results indicate that what applies to other ethnic
populations might not apply to the AA population, and that the
association between adiponectin and insulin sensitivity needs to
be clarified in the AA population.
The studies indicate that polymorphisms at the adiponectin
locus are predictors of circulating adiponectin levels, insulin sen-
sitivity, and atherosclerosis, highlighting the pivotal role of this
adipokine in the modulation of metabolism and atherogenesis
(Menzaghi et al., 2007). Several genetic loci are determinants of
adiponectin levels, genetic determinants that taken together influ-
ence risk of type 2 diabetes and insulin resistance (Dastani et al.,
2012). Variability at the adiponectin locus associated with obe-
sity and other features of the insulin resistance syndrome has
been studies intensively in the last years (Comuzzie et al., 2001;
Menzaghi et al., 2007), but a limited number of studies have
examined the role of heredity in the regulation of adiponectin
among individuals of African heritage (Miljkovic-Gacic et al.,
2007). Estimates of adiponectin heritability (adjusted for age,
gender, and BMI) in two populations of African descent were
0.45 and 0.70 for the African American and Nigerian fami-
lies, respectively, indicating a relatively high genetic determi-
nant for adiponectin levels (Hicks et al., 2007). As our recent
Mendelian randomization collaborative study indicated, by using
an ADIPOQ genetic summary risk score, no evidence of an
association between adiponectin-lowering alleles and insulin sen-
sitivity or type 2 diabetes appears present (Yaghootkar et al.,
2013). As our results suggest, measures of global individual ances-
try obtained with relevant frequency genetic markers might be
helpful for controlling spurious associations—relevant to this
important adipokine—detected in population studies due to pop-
ulation stratification and admixture.
Our study showing a direct association between global propor-
tion of European ancestry and adiponectin suggests that genetic
factors are a significant source of inter-individual differences
in circulating adiponectin among AAs. Moreover, as the effect
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modification (interaction) of obesity and insulin resistance sta-
tus of the relation of adiponectin levels with PEA indicates, a
complex interplay among specific genetic loci and non-genetic
factors, which may both be associated with the overall admixture,
might lead to the observed ethnic differences in cardio-metabolic
risk. As we have shown (Bidulescu et al., 2013b), in JHS there
are negative correlations between adiponectin and many of the
CVD risk factors yet the women, who have higher adiponectin
levels than men, also have higher CVD risk factors. If adiponectin
acts as a compensatorymechanism to counteract these risk factors
warrants additional studies.
An alternative mechanistic explanation for our findings may
be that the association between ancestry and adiponectin is due
to some non-genetic confounders, which were not characterized
in our investigation. Although we adjusted for many of the known
correlates of adiponectin levels, it is possible that other differences
in medical treatment or additional socioeconomic and psychoso-
cial factors for which we do not have information may underlie
some of the observed associations.
STRENGTHS AND LIMITATIONS
Our study sample is localized to one geographical area and one
ethnic group, so generalizability inherently cannot be inferred.
As an “aggregate” measure, the global individual proportion of
European ancestry might not capture the genetic influences of
specific genetic regions. These caveats are compensated by the fact
that we used a large number of AIMs, and were able to control for
a large number of potential confounders in a large sample of AAs.
CONCLUSION
Our study results point to the interaction of genetic and
metabolic factors as variables associated with the lower levels of
adiponectin in AAs. It warrants thus further exploration of the
role ancestry plays in the complex relationship of adiponectin
with cardio-metabolic risk factors.
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